Cancer Horizons
A weekly podcast powered by CURE (https://www.curetoday.com/) , on what we do best: provide Cancer Updates Research and Education.
Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones.
As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable.
To learn more, you can also visit us on Facebook (https://www.facebook.com/curemagazine) , Twitter (https://twitter.com/cure_today) and Instagram (https://instagram.com/curetoday) !
- Update frequency
- every 7 days
- Average duration
- 16 minutes
- Episodes
- 294
- Years Active
- 2018 - 2025
S7 Ep1: The Importance of Spotting Endometrial Cancer
Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai…
00:10:25 |
Tue 18 Mar 2025
S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another c…
00:07:46 |
Mon 04 Mar 2024
S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, a…
00:10:12 |
Mon 04 Mar 2024
S6 Ep20: FDA Approvals from February 2024
Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers.…
00:06:26 |
Fri 23 Feb 2024
S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development
Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tu…
00:09:03 |
Mon 19 Feb 2024
S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered resear…
00:07:13 |
Mon 12 Feb 2024
S6 Ep17: FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
Last week, we saw some research regarding how a popular tool used to plan breast cancer treatment may be misguiding therapy for Black women, as well as an update on when we can expect to see a new ca…
00:09:13 |
Mon 05 Feb 2024
S6 Ep16: Highlights from the Gastrointestinal and Genitourinary Cancer Conferences
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
00:08:57 |
Tue 30 Jan 2024
S6 Ep15: Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy
Last week, we saw some big headlines in the oncology space, from Dexter Scott King’s death from prostate cancer and MLB Hall-of-Famer Ryne Sandberg announcing that he was diagnosed with the disease.
…
…
00:07:29 |
Mon 29 Jan 2024
S6 Ep14: How a Cancer Journey Connects Oncologist to His Patients
Often, receiving a cancer diagnosis can require a crash course in oncology that few patients ever expected to take.
For colorectal cancer specialist Dr. Dustin Deming, the ACI/Schwenn Family associa…
For colorectal cancer specialist Dr. Dustin Deming, the ACI/Schwenn Family associa…
00:07:58 |
Thu 25 Jan 2024
S6 Ep13: A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
It wasn’t even two weeks into the new year when the Food and Drug Administration made their first FDA approval. In this case, it was a Keytruda regimen for certain patients with gynecologic cancers. …
00:10:25 |
Mon 22 Jan 2024
S6 Ep12: FDA Gives Cancer Drug Updates, Prostate Cancer Trial Enrolls Patients
Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.
00:10:46 |
Mon 15 Jan 2024
S6 Ep11: ‘Stand Up For Yourself’: Facing Thyroid Cancer With Urgency, Positivity
Kate Rice is proof of the power of persistence and positivity while navigating a cancer journey.
Rice, an award-winning journalist, received a diagnosis of stage 4 anaplastic thyroid cancer in Octob…
Rice, an award-winning journalist, received a diagnosis of stage 4 anaplastic thyroid cancer in Octob…
00:11:29 |
Wed 10 Jan 2024
S6 Ep10: FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Notably, we have a clinical trial hold for a lung cancer drug, a trial …
Notably, we have a clinical trial hold for a lung cancer drug, a trial …
00:07:11 |
Mon 08 Jan 2024
S6 Ep9: Top Cancer Headlines from 2023: From Jimmy Buffett’s Death to the Chemo Shortage
The year 2023 has come and gone, and we figured that now is the perfect time to look back on some of the top cancer-related stories from the year.
00:07:44 |
Tue 02 Jan 2024
S6 Ep8: FDA Approves 3 Treatments, Cancer Vaccine Shows Promise
The FDA is certainly staying busy as 2023 comes to a close, approving three treatments for patients with cancer last week alone.
Additionally, exciting study findings were released regarding a cance…
Additionally, exciting study findings were released regarding a cance…
00:08:16 |
Wed 20 Dec 2023
S6 Ep7: Conference Highlights from the 2023 ASH Annual Meeting
This past weekend, the CURE® staff was busy covering the American Society of Hematology (ASH) Annual Meeting.
ASH is the largest blood cancer conference in the country, and thousands of abstracts we…
ASH is the largest blood cancer conference in the country, and thousands of abstracts we…
00:06:46 |
Wed 13 Dec 2023
S6 Ep6: Conference Highlights from SABCS
The last week was a busy one for us here at CURE® and across the oncology space in general. There were two major meetings we covered: the San Antonio Breast Cancer Symposium and the American Society …
00:07:23 |
Mon 11 Dec 2023
S6 Ep5: Top Headlines on CAR-T Cell Therapy
Blood cancer treatments — and one treatment type, in particular — were the point of much discussion last week. The FDA said that it is investigating instances of secondary malignancies in patients wi…
00:04:58 |
Mon 04 Dec 2023
Disclaimer: The podcast and artwork embedded on this page are the property of CURE Talks Cancer. This content is not affiliated with or endorsed by eachpod.com.